EXHIBIT 99.1 Iterum Therapeutics Reports First Quarter 2025 Financial Results --Preparing for Potential Launch of ORLYNVAHTM by Q4 2025— --Extended Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, May 13, 2025 -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial re ...